Intracellular pathways of pancreatic β-cell apoptosis in type 1 diabetes

Helen E Thomas1, Thomas W Kay

  • 1St Vincent's Institute of Medical Research, Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Melbourne, Victoria, Australia. hthomas@svi.edu.au

Abstract

Insights

Bid protein protects beta cells from diabetes-related damage. Targeting Bid may prevent beta cell death in type 1 diabetes and islet transplantation. This research clarifies apoptosis pathways in diabetes.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Immunology

Background:

  • Beta cell apoptosis is a hallmark of type 1 diabetes.
  • Beta cell loss is also observed in type 2 diabetes and islet graft rejection.

Purpose of the Study:

  • To investigate intracellular pathways regulating beta cell apoptosis in diabetes.
  • To examine the role of Bid, a pro-apoptotic Bcl-2 family member, in beta cell death.
  • To identify Bcl-2 family molecules involved in killing induced by high glucose concentrations.

Main Methods:

  • Studied intracellular pathways regulating beta cell apoptosis in type 1 and type 2 diabetes.
  • Utilized islets from Bid-deficient mice to assess Bid's role.
  • Investigated Bcl-2 family molecules involved in cell death induced by high glucose or ribose.

Main Results:

  • Bid-deficient islets showed protection against perforin, granzyme B, and Fas-mediated killing.
  • Bid deficiency offers a potential therapeutic target for protecting beta cells from type 1 diabetes insults.
  • Islets lacking Bim or Puma, but not Bid, were protected from glucose toxicity.

Conclusions:

  • Different stimuli activate distinct initiator molecules within the Bcl-2-regulated apoptosis pathway in beta cells.
  • Bid plays a crucial role in mediating beta cell apoptosis induced by immune and cytotoxic insults relevant to type 1 diabetes.
  • Bim and Puma are key mediators of glucose-induced beta cell toxicity.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...